Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-799 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-799 Cr
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr
Mar2020₹-1,091 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr
Negative
Mar2020 ₹-1,091 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹158,673.4 Cr 2.4% 2.2% 59.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics
MANKIND PHARMA ₹96,821.9 Cr -2.1% -10.9% 7.9% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.4%

2.2%

59.7%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses